You have 9 free searches left this month | for more free features.

CMML

Showing 176 - 200 of 200

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia Trial in Austria (Revlimid)

Unknown status
  • Chronic Myelomonocytic Leukemia
  • Linz, Oberösterreich, Austria
  • +9 more
Mar 6, 2015

Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States

Completed
  • Leukemia, Myelocytic, Acute
  • +3 more
  • Duarte, California
  • +23 more
Feb 8, 2016

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Kashiwa, Tokyo (Oral azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • +5 more
  • Oral azacitidine
  • Kashiwa, Chiba, Japan
  • +2 more
Jul 24, 2015

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Houston (Clofarabine)

Completed
  • Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Oct 8, 2015

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in France (Lenalidomide)

Unknown status
  • Myelodysplastic Syndrome
  • +2 more
  • Angers, France
  • +24 more
Apr 23, 2015

Chronic Myelomonocytic Leukemia Trial in France (Decitabine)

Completed
  • Chronic Myelomonocytic Leukemia
  • Le Kremlin-BicĂȘtre, Ile de France, France
  • +30 more
Mar 19, 2014

Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) Trial in Durham (WT1

Terminated
  • Acute Myelogenous Leukemia (AML)
  • +4 more
  • WT1 derived peptides
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Dec 7, 2013

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Denmark, Norway, Sweden (Azacitidine, Erythropoetin)

Completed
  • Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • Aalborg, Denmark
  • +16 more
Oct 28, 2013

Leukemia Trial in Leeds, Glasgow (azacitidine, laboratory biomarker analysis)

Completed
  • Leukemia
  • Leeds, England, United Kingdom
  • +1 more
Aug 23, 2013

Myelodysplastic Syndrome Trial in Houston (AR-67 (20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin))

Unknown status
  • Myelodysplastic Syndrome
  • AR-67 (20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin)
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 23, 2014

Cancer Trial in Worldwide (GSK1120212)

Completed
  • Cancer
  • Birmingham, Alabama
  • +27 more
Mar 6, 2014

Leukemia Trial in Houston (3 Day Thiarabine, 5 Day Thiarabine)

Completed
  • Leukemia
  • 3 Day Thiarabine
  • 5 Day Thiarabine
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 16, 2014

Chronic Myelomonocytic Leukemia, Previously Treated MDS, Recurrent Adult Acute Myeloid Leukemia Trial in Houston (liposomal

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • liposomal daunorubicin citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

MDS Trial in Tampa (Dasatinib)

Completed
  • Myelodysplastic Syndromes
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 21, 2013

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Apr 1, 2013

Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Houston (DTGM)

Terminated
  • Acute Myelogenous Leukemia
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Feb 20, 2012

Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Myelodysplastic Syndrome
  • decitabine (5-aza-2'deoxycytidine)
  • Berkeley, California
  • +23 more
Jan 22, 2013

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Houston (Bendamustine)

Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2012

Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)

Terminated
  • Chronic Myelogenous Leukemia
  • +4 more
  • CD8 Depleted Donor Lymphocyte
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 22, 2012

MDS Trial in France (BEVACIZUMAB)

Terminated
  • Myelodysplastic Syndromes
  • Avignon, France
  • +9 more
Dec 7, 2011

Hematological Disease, Lymphoid Malignancies Trial in Belgium, France, Netherlands (CHR-2845)

Completed
  • Hematological Disease
  • Lymphoid Malignancies
  • Antwerp, Belgium
  • +3 more
Nov 25, 2011

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in London (Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • +2 more
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
Sep 2, 2010

Biological Data With Potential Prognostic Relevance in

Unknown status
  • Myelodysplastic Syndrome
    • Coppito, L'Aquila, Italy
    • +13 more
    Feb 7, 2011

    Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Worldwide (decitabine)

    Unknown status
    • Leukemia
    • +2 more
    • Innsbruck, Austria
    • +45 more
    Apr 10, 2010